|
| |
| | | 69936 | | 08.08.2024 | | Hasten Biopharmaceutic (Switzerland) AG | | | | | | | | | | | | | | | | | 02.07.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Hanarbe 20 mg | Tabletten | Tablets (Azilsartanum Medoxomilum 20 mg) | C09CA09 | CI | | 02 | Hanarbe 40 mg | Tabletten | Tablets (Azilsartanum Medoxomilum 40 mg) | C09CA09 | CI | | 03 | Hanarbe 80 mg | Tabletten | Tablets (Azilsartanum Medoxomilum 80 mg) | C09CA09 | CI |
|
|
|
